ADVFN - Advanced Financial Network.
HOME» LSE » G » GSK Share Price » GSK Share News

Glaxosmithkline Share News

 Glaxosmithkline Share Price
GSK Share Price
 Glaxosmithkline Share Chart
GSK Share Chart
 Glaxosmithkline Share News
GSK Share News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Share Trades
GSK Share Trades
 Glaxosmithkline Share Message Board
GSK Share Message Board

GlaxoSmithKline to close Crawley factory in Sussex, 493 jobs to go

LONDON (Thomson Financial) - GlaxoSmithKline PLC. has announced hundreds of people will lose their jobs when it closes its factory in Sussex in 2011, the BBC reported citing a company spokesman. Some 493 people are expected to be affected when the multinational drugs company's Crawley site closes. The company blamed the closure on "declining volumes, regulatory delays and patent expiries". A spokesman said production at the site would continue until the products had been moved to alternative facilities. The spokesperson said: "GSK sincerely regrets the potential impact of this proposal in terms of job losses and will do all it can to help staff through this difficult period. "Implementation of this proposal will be subject to consultation with trade union and staff representatives at the Crawley site. This process will begin immediately." The factory currently produces medicines to treat Parkinson's disease, heart disease, HIV/AIDS, bacterial skin infections, depression, and hypertension. slm COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

Share News for Glaxosmithkline (GSK)
20/10/201414:05:46GlaxoSmithKline plc 3Q 2014 -- Forecast
07/10/201417:17:17LONDON MARKETS: FTSE 100 Falls Amid Broader European Selloff
01/10/201410:55:10MARKET SNAPSHOT: U.S. Stocks: Futures Flatten Ahead Of ADP Employment...
29/09/201412:42:08Glaxo Reports 45% Survival Rate in Melanoma Drug Trial
25/09/201423:18:07ADR Shares End Lower; Orange Shares Trade Actively
25/09/201415:00:11LONDON MARKETS: FTSE 100 Slips After Carney Hints Rate Hike Looms
25/09/201414:45:20U.S. Hot Stocks: Hot Stocks to Watch
25/09/201413:15:50LONDON MARKETS: FTSE 100 Wavers Ahead Of Carney Speech
25/09/201412:47:27EUROPE MARKETS: H&M Slides; Telecom Italia Rises: Europe's Big...
25/09/201410:31:15EUROPE MARKETS: H&M Slides; Air France Rises: Europe's Big Stock...
25/09/201410:00:12GSK Names RBS's Philip Hampton as Chairman
25/09/201409:31:34LONDON MARKETS: Direct Line Leads FTSE Higher For Second Day
25/09/201408:57:32GlaxoSmithKline Names RBS's Philip Hampton as Chairman
24/09/201416:10:38GSK to Name Philip Hampton as Next Chairman -Sky News
22/09/201417:43:39Germany's Merck to Buy Sigma-Aldrich for $17 Billion--2nd Update
19/09/201423:33:14ADR Shares End Lower; GlaxoSmithKline, SAP Shares Trade Actively
19/09/201415:11:07MARKET SNAPSHOT: U.S. Stocks Rise; S&P 500, Dow Hit Records
19/09/201414:24:13MARKET SNAPSHOT: U.S. Stocks: Futures Higher As Fed Rate View...
16/09/201415:25:32Five Prime: Glaxo Exercises Option for Rights to Muscle-Disease...
09/09/201406:47:43GSK Announces Results of Late-Stage PAH Trial With Gilead

Glaxosmithkline Plc and other London Stock Exchange share prices are delayed by at least 20 minutes.
All other share price data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations